SCHEMBL6693347

SCHEMBL6693347

Cc1cccc(Cn2c3cccc(O)c3c3c(C(N)=O)cccc32)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 2/20 0.51
ADRA1D P25100 1/20 0.46
F10 P00742 4/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
ALDH1A1 P00352 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SRC P12931 1/20 0.43
PRKACA P17612 1/20 0.43
PRKACG P22612 1/20 0.43
PRKACB P22694 1/20 0.43
MAPK8 P45983 1/20 0.43
F2 P00734 1/20 0.42
PARP1 P09874 2/20 0.41
PARP2 Q9UGN5 2/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
KCNH2 Q12809 1/20 0.41
ERCC5 P28715 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6691732 0.92 ADRA1D (0.44) PLA2G2AADRA1DF10MEN1KMT2A
SCHEMBL6694031 0.91 PLA2G2A (0.48) PLA2G2AADRA1DF10ALDH1A1MAPK8
SCHEMBL6774766 0.89 ALDH1A1 (0.43) PLA2G2AADRA1DF10MEN1KMT2A
SCHEMBL6774185 0.88 TP53 (0.47) PLA2G2AADRA1DF10MEN1KMT2A
SCHEMBL6775864 0.87 ADRA1D (0.41) PLA2G2AADRA1DF10MEN1KMT2A
SCHEMBL30410966 0.87 ADRA1D (0.46) PLA2G2AADRA1DMEN1KMT2AALDH1A1
SCHEMBL29029780 0.87 ADRA1D (0.46) PLA2G2AADRA1DMEN1KMT2AALDH1A1
SCHEMBL5212989 0.86 PLA2G2A (0.58) PLA2G2AADRA1DF10MEN1KMT2A
SCHEMBL6690384 0.86 MAPT (0.52) PLA2G2AF10MEN1KMT2AALDH1A1
SCHEMBL6778315 0.85 F10 (0.46) PLA2G2AF10MAPK8PARP1PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0950657-B1 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors LILLY CO ELI (US) 2004-07-14 EP disclosed
EP-0952149-B1 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors LILLY CO ELI (US) 2004-06-09 EP disclosed
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed
EP-0950657-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors ELI LILLY AND COMPANY (US) 1999-10-20 EP disclosed